Evaluation Study for its Clinical Utility of Gene Prognostic Signature MammaPrint for Early-Breast Cancer
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Registration Number
- JPRN-UMIN000002834
- Lead Sponsor
- Department of Breast and Endocrine Surjery, Juntendo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Developed malignancy except carcinoma in situ 2. Received Neo-adjuvant therapy treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation to decide breast cancer adjuvant therapy and treatment by applying MammaPrint to each patient to see if prognosis by gene expression profiling.
- Secondary Outcome Measures
Name Time Method